$20MSeries A, 16 October 2025
Funds complete end-to-end regulatory lifecycle coverage and expansion into Europe, Japan and Latin America.
- Amount
- $20M
- Stage
- Series A
- Announced
- 16 October 2025
- Lead
- USVP
- Other investors
- Innovation Endeavors, Magnetic Ventures, Character, TMV, Serrado Capital
- Use of funds
- Funds complete end-to-end regulatory lifecycle coverage and expansion into Europe, Japan and Latin America.
- Checked
- Announced by the company
- Sources
- Weave Bio Secures $20M Series A Funding to Enhance Its AI-Native Regulatory Platform - Business Wire businesswire.com
Weave Bio Secures $20M Series A Funding to Enhance Its AI-Native Regulatory Platform - Business Wire Business Wire